SAN FRANCISCO — Obeticholic acid maintains reduced levels of key biomarkers for primary biliary cholangitis (previously known as primary biliary cirrhosis) for up to 5 years, according to the results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback